<DOC>
	<DOCNO>NCT01162291</DOCNO>
	<brief_summary>The purpose experimental pilot study assess positive effect high injection volume fluid ( physiological sodium ) elbow-flection-muscle ( M. biceps brachii ) elbow flexion extension movement fluid distribution muscle tissue .</brief_summary>
	<brief_title>Comparison Intramuscular Distribution Different Injection Volumes Via Diffusion Tensor Imaging ( DTI )</brief_title>
	<detailed_description>Background : Intramuscular application Botulinum toxin use successful therapy many condition ( e.g . spasticity , movement disorder , hypersecretory disorder , ophthalmic disorder , painful condition , pelvic floor gastrointestinal disorder , cosmetic application ) Clinical practice show even use special guidance technique ( electromyography ( EMG ) , ultrasound , electrical stimulation ) increase accuracy target , botulinum toxin may spread adjacent site diffusion . Different therapy goal request variable diffusion toxin , depend number muscle involve loss function affect area , respectively . There evidence large injection volume lead great distribution large affected area . Thus , animal model show increased efficacy decrease systemic side effect botulinum toxin A injected muscle active passive manipulation muscle . Magnetic resonance imaging ( MRI ) potential noninvasively probe amount motion intracellular extracellular water use different sequence . T2-weighted diffusion tensor sequence especially useful quantification characterization chemical behaviour water different ( animal ) tissue type . To knowledge systematically perform vivo MR study use image technique visualization intramuscular dilution fluid human subject . However , vivo effect tissue distribution different injection volume active muscle movement human via DTI never observe . Hypothesis : Intramuscular distribution common saline solution non-invasively quantify DTI human subject . DTI use elucidate : - Intramuscular distribution favour large injection volume - Intramuscular distribution facilitate active muscle activity . Rationale : The effect large injection volume active muscle activity injection intramuscular toxin distribution uptake remain unclear . Physiological sodium carrier material preparation Botulinum toxin , suggest physiological sodium natriumchlorid ( NaCl ) distribution representative toxin primary distribution . Dynamic T2-weighted sequence may monitor inflow regional distribution infuse saline solution . DTI non-invasively quantify amount directionality motion proton human skeletal muscle may therefore indirectly allow assumption extra- intracellular distribution infuse solution/substance . Methods : In exploratory , investigator blind pilot study , 10 healthy subject investigate DTI musculi biceps brachii randomise intramuscular injection two different injection volume NaCl randomisation active flexion extension elbow joint versus active flexion extension . During injection dynamic T2 weight magnetic resonance tomographic sequence perform . Subsequently diffusion tensor sequence carry defined time point .</detailed_description>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>healthy volunteer willing participate clinical pilot trial age 1880 year old bleeding disorder acute bleed event coumarines , warfarin therapy type medical implant ( pacemaker , prosthesis , etc . ) meet general safety recommendation 3 tesla MR imaging</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2012</verification_date>
	<keyword>intramuscular</keyword>
	<keyword>distribution</keyword>
	<keyword>NaCl</keyword>
	<keyword>botulinum toxin</keyword>
	<keyword>muscle</keyword>
	<keyword>volume</keyword>
	<keyword>movement</keyword>
	<keyword>biceps brachii</keyword>
	<keyword>primary distribution intramuscular NaCl representative primary distribution intramuscular botulinum toxin</keyword>
	<keyword>shift extracellular intracellular view DTI technology</keyword>
	<keyword>effect volume</keyword>
	<keyword>effect muscle movement</keyword>
</DOC>